期刊文献+

子宫内膜异位症术后GnRH-a治疗与黑升麻制剂的使用 被引量:7

Post-operative GnRH-a treatment and black cohosh preparations administration in endometriosis patients
在线阅读 下载PDF
导出
摘要 子宫内膜异位症(EMS)是临床上最常见的妇科疾病之一,术后的复发问题一直困扰着临床医师。促性腺激素释放激素激动剂(GnRH-a)的使用对于降低EMS术后的复发具有十分重要的作用,目前已成为临床上最为常用的预防EMS复发的方法。但是,GnRH-a使用后引发的围绝经期症状严重影响患者的生活质量,部分患者因此而终止治疗。激素反向添加治疗虽然很好的解决了围绝经期症状,但是激素的长期使用可能导致激素依赖性疾病的风险。作为一种植物提取物,黑升麻制剂能否较好的拮抗GnRH-a所致类围绝经期症状,而且又能避免激素反向添加治疗的风险,目前尚不明确。该文主要围绕EMS术后GnRH-a治疗的必要性及其存在的问题,黑升麻制剂的作用机制与功能,黑升麻用于缓解EMS患者术后使用GnRH-a治疗出现的类围绝经期症状的可能性及可能存在的问题进行概述。 Endometriosis ( EMS) is one of the most common gynecological diseases in clinics , and the postoperative recurrence has always plagued clinicians .Usage of gonadotropin releasing hormone agonist ( GnRH-a) is very important for reducing EMS recurrence , and it has become the most commonly used method for preventing EMS recurrence .However , perimenopausal symptoms induced by GnRH-a usage seriously affect patients’ life quality, and some patients terminate the treatment because of it .Although add-back therapy is a very good solution for menopausal symptoms , long-term use of hormone may lead to hormone-dependent disease risk .It is still not clear whether black cohosh preparations , as a kind of plant extracts , can be a better antagonism of menopausal symptoms caused by GnRH-a administration and avoid the risk of hormone add-back therapy .This paper will mainly focus on the necessity and existing problems of post-operative GnRH-a treatment for EMS patients , mechanism and functions of black cohosh preparations , possibility and the problems of using black cohosh for remission of perimenopausal symptoms induced by postoperative GnRH-a administration in EMS patients .
出处 《中国妇幼健康研究》 2014年第2期344-347,共4页 Chinese Journal of Woman and Child Health Research
  • 相关文献

参考文献15

  • 1Meola J,Rosae Silva J C,Dentillo D B,et al.Differentially expressed genes in eutopic and ectopic endometrium of women with endometriosis [J].Fertil Steri1,2010,93(6):1750-1773.
  • 2Sha G,Wu D,Zhang L,et al,Differentially expressed genes in human endornetrial endothelial cells derived from eutopic endometrium of patients with endometriosis compared with those from patients without endometriosis [J].Hum Reprod,2007,22(12):3159-3169.
  • 3Lin N U,Winer E P.Advances in adjuvant endocrine therapy for postmenopausal women [J].J Clin Oncol,2008,26(5):798-805.
  • 4Powell S L,Godeck T,Nikolic D,et al.In vitro serotonergic activity of black cohosh and identification of N-methylserotonin as a potential active constituent [J].J Agric Food Chem,2008,56(24):11718-11726.
  • 5Ruhlen R L,Sun G Y,Sauter E R.Black cohosh:insights into its mechanism(s)of action [J].Integrative Medicine Insights,2008,3(1):21-32.
  • 6Kharode Y,Bodine P V,Miller C P.The pairing of a selective estrogen receptor modulator,bazedoxifene,with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention [J].Endocrinology,2008,149(12):608445091.
  • 7Li J X,Liu J,He C C,et al.Triterpenoids from Cimicifugae rhizome,a novel class of inhibitors on bone resorplion and ovariectomy induced bone loss[J].Maturias,2007,58(1):59-69.
  • 8Rebbeck T R,Troxel A B,Norman S,et al.A retrospective case control study of the use of hormone related supplements and association with breast cancer [J].Int J Cancer,2007,120(7):1523-1528.
  • 9Bosker F J,Folgering J H,Gladkevich A V,et aL Antagonism of 5-HT1A receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity,an action probably mediated by 5-HT7 receptors [J].J Neurochem,2009,108(5):1126-1135.
  • 10Freitas R L,Ferreira C M,Urbina M A,et al.5-HT1A/1B,5-HT6,and 5-HT7 serotonergic receptors recruitment in tonicclonic seizure-induced antinociception:Role of dorsal raphenucleus [J].Exp Neuro1,2009,217(1):16-24.

同被引文献52

  • 1薛赛琴,姜坤,张琼.希明婷片治疗女性更年期综合征364例[J].中国中西医结合杂志,2006,26(10):891-891. 被引量:8
  • 2金华,张秋霞.黑升麻肝毒性报告引起各国药政部门的关注[J].国外医药(植物药分册),2006,21(6):249-250. 被引量:1
  • 3子宫内膜异位症的诊断与治疗规范[J].中华妇产科杂志,2007,42(9):645-648. 被引量:570
  • 4Yamaguti EM, Brito MB, Ferriani RA, et al. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis : a randomized clinical trial [J]. Thromb Res, 2014, 134 (6) : 1193-1197.
  • 5Shinohara A,Kulsukake M,Fakahashi M,elal.Prote a seactivat-ed receptor-stimulated interleukin-6 expression in endometriosis-like lesions in an experimental mouse model of endometriosis[J].J Pharmaco Sci,2012,119(1):40-51.
  • 6Seracchioli R, Mabrouk M, Frasc0 C, et al. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial[ J ]. Fertil Steri1,2010,94 (2) :464-471.
  • 7Vercellini P, Somigliana E, Viganb P, et al. Endometriosis : current therapies and new pharmacological developmentsl Jl. Drugs,2009, 69 ( 6 ) : 649-675.
  • 8Seracchioli R, Mabrouk M, Manuzzi L, et al. Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis J]. Hum Reprod,2009,24( l 1 ) :2729-2735.
  • 9Ruhland B, Agic A, Krampe J, et al. Innovations in conservative endometriosis treatment: an updated review[ J]. Minerva Ginecol, 2011,63 (3) :247-259.
  • 10Vlahos N, Vlachos A, Triantafyllidou O, et al. Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis : a prospective cohort study I J ] Fertil Steril, 2013, 100(5) :1337-1342.

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部